Almost 50% of #cancers are found in later stages, but many have a higher survival rate when found early, making #CancerScreening vital. Aristotle® can help detect the molecular signatures of multiple cancers from a single sample of blood. https://t.co/lHOIO6CwYW
$SZLS, $SZLSF
StageZero Life Sciences’ Clinical Business Introduces Fourth Pillar to Cancer Offerings.
Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patients. https://t.co/vnDcLhWN0M
#cancer $SZLS $SZLSF #mentalhealth#stagezerolifesciences
StageZero Life Sciences’ Clinical Business Introduces Third Pillar to Cancer Offerings.
Read the full release at https://t.co/yKNptXYCO7
#cancer#earlymakescents $SZLS #oncologynutrition
Today is Glioblastoma Awareness Day. Our METRICS study with glioblastoma patients laid the foundation of our COC protocol. Survival rates were positively impacted. Read the study here: https://t.co/SiyCBVRglw #GMBDay#cancer#earlydetection $SZLS $SZLSF #earlymakescents
1. Insurance companies can utilize SZLS Tests such as Aristotle and AVRT to reduce the overall risk, costs and subsequently premiums. $SZLS $SZLSF #earlymakescents#earlydetection
Listen to SZLS’ Chairman and CEO, James Howard-Tripp talk about partnerships and how they are benefiting the Company. https://t.co/mxrY3OvHz6 $SZLSF $SZLS #stagezero#growth#cancer#earlydetection
StageZero Life Sciences welcomes Health Today into its partnership network. Health Today is focused on serving employers and individuals in Alberta with access to innovative tests for early detection of disease. $SZLS $SZLSF #earlymakescents#earlydetection
StageZero is successfully expanding its reach. New clinics in W. Cda and the US are going live. Our partnering approach is innovative, we work w/ employers, patients, & clinical groups offering Aristotle, AVRT + COC Clinic oncologist/physician support $SZLSF $SZLS #earlydetection
StageZero Life Sciences, Ltd. this morning announced a temporary repricing of warrants that are expiring in 2023 and 2024 for the period of July 5 - 10, 2023; new exercise price CDN$0.065. https://t.co/5F1BCbdNat #stagezero#earlydetection $SZLSF $SZLS
What do our ideal partnerships look like? Listen to our CEO give insight into who might be an ideal partner. https://t.co/SMkeNEhUJ9
$SZLS $SZLSF #earlydetection#cancer